Additionally, indicators of endothelial dysfunction, including soluble vascular cell adhesion molecule-1 (sVCAM-1) and pentraxin-3 (PTX3), may help differentiate NBD from other neuroinflammatory conditions and monitor therapeutic efficacy [136]. Here, PTX3 is linked to endothelial dysfunction.